Group 1 - The Rosen Law Firm is reminding purchasers of Applied Therapeutics, Inc. securities of the lead plaintiff deadline on February 18, 2025, for a class action lawsuit [1] - Investors who purchased securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting the Rosen Law Firm [3][6] Group 2 - The lawsuit alleges that Applied Therapeutics made false and misleading statements regarding its clinical trial protocols, which created a risk of FDA rejection of trial data [5] - The firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the legal field [4]
APLT DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Applied Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT